Is Moderna Inc. (NASDAQ:MRNA) the Top Gene Therapy Stock to Invest in Now?
Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a disease.
Stay updated with breaking news from Life Edit. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Gene therapy involves treating illnesses by modifying, replacing, or supplementing faulty or missing genes responsible for a disease.
Reports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula; reaffirms 2024 expected product sales of approximately $4 billionInitiated three new clinical studies evaluating Moderna's investigational...
WALTHAM, Mass.--(BUSINESS WIRE)--Apr 22, 2024--
Explore Boston's vibrant biotech landscape with twelve innovative companies leading the charge in life sciences research.
Genome editing refers to a set of technologies enabling scientists to modify an organism's DNA by adding, removing, or altering genetic material at specific locations in the genome, as defined by MedlinePlus...